The Containerized Bio-Containment System (CBCS) by MRIGlobal is uniquely engineered to support and facilitate the safe transport and treatment of patients infected with highly contagious pathogens while safeguarding the medical staff, flight crew and the aircraft. The CBCS, , a 2016 R&D 100 award winner, built upon years of bio-containment knowledge to provide a solution that maintains containment even in the event of emergency landings or mid-air rapid decompression events to assure the medical staff and flight crew of their safety at all times. Development of the CBCS required combining the challenges of bio-containment and flight worthiness requirements while meeting a short 191-day development cycle. The development team incorporated lessons learned from the recent Ebola outbreak and the collective expertise of bio-containment, custom fabrication and R&D experts to deliver an extensively analyzed and experimentally validated system in the abbreviated timeline.
Each year for more than 50 years, R&D Magazine has honored the 100 best innovations in research and development. We are currently accepting applications for the 2017 R&D 100 Awards. Innovators with an exceptional product developed between January 1, 2016 and March 31, 2017 should apply. Submissions close April 14, 2017
For information on the 55th Annual R&D 100 Awards and to enter visit http://www.rd100conference.com
